Two sides of the medallion: poor treatment tolerance but better survival by standard chemotherapy in elderly patients with advanced-stage diffuse large B-cell lymphoma.

SAM van de Schans, ANM Wymenga, DJ van Spronsen, HC (Harry) Schouten, Jan Willem Coebergh, Maryska Heijnen

Research output: Contribution to journalArticleAcademicpeer-review

39 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)1280-1286
Number of pages7
JournalAnnals of Oncology
Volume23
Issue number5
DOIs
Publication statusPublished - 2012

Research programs

  • EMC NIHES-02-65-02

Cite this